Vascular Medicine News

ATLANTA — Intravascular ultrasound-guided PCI lowered risk for target vessel failure vs. an angiography-guided approach for patients with acute coronary syndrome, a speaker reported.

Disruptions in endothelial function caused by brief bouts of elicited anger may be an early predictor of heart disease, but the underlying mechanism remains unclear, researchers reported.

Abbott announced the FDA has approved its novel below-the-knee, bioresorbable, drug-eluting scaffold for people with chronic limb-threatening ischemia.

Researchers have discovered the mechanisms by which the chemotherapy drug ponatinib harms the heart.

Researchers found a U-shaped association between alcohol consumption and risk for peripheral artery disease, with the lowest risk seen with consuming two drinks per week and more pronounced risk with at least 10 drinks, study data showed.

Air pollution accentuates the relationship between poor mental health and premature mortality from heart disease in the United States, researchers reported at ESC Preventive Cardiology 2024.

Few areas in cardiology are as active as development and implementation of medical therapies for heart failure, and few people are as familiar with that landscape as Javed Butler, MD, MPH, MBA, FACC, FAHA, FESC.

Penumbra announced the FDA clearance and launch of its next-generation computer-assisted vacuum thrombectomy system to remove venous thrombus and treat pulmonary emboli.

Less than optimal heart health at midlife was associated with a decline in the mental processing speed of Black women, but not white women, researchers reported.

Adults with endogenous Cushing’s syndrome had reductions in blood pressure and glucose at 22 weeks of treatment with a selective cortisol modulator, according to topline results from the open-label portion of the GRACE phase 3 trial.